3 assets in X-Linked Disease

Therapeutic assets addressing X-Linked Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Aoc 1044 X-Linked Disease	Avidity Biosciences, Inc.	P3	B (60)
Deramiocel X-Linked Disease	Capricor Inc.	P3	B (60)
Zeleciment Rostudirsen X-Linked Disease	Dyne Therapeutics	P3	B (60)